WDNA vs. XBI
Compare and contrast key facts about WisdomTree BioRevolution Fund (WDNA) and SPDR S&P Biotech ETF (XBI).
WDNA and XBI are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. WDNA is a passively managed fund by WisdomTree that tracks the performance of the WisdomTree BioRevolution Index. It was launched on Jun 3, 2021. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006. Both WDNA and XBI are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WDNA or XBI.
Correlation
The correlation between WDNA and XBI is 0.91, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
WDNA vs. XBI - Performance Comparison
Key characteristics
WDNA:
-0.48
XBI:
0.41
WDNA:
-0.53
XBI:
0.74
WDNA:
0.94
XBI:
1.09
WDNA:
-0.22
XBI:
0.20
WDNA:
-1.11
XBI:
1.29
WDNA:
9.43%
XBI:
8.18%
WDNA:
22.02%
XBI:
25.90%
WDNA:
-51.90%
XBI:
-63.89%
WDNA:
-47.12%
XBI:
-47.44%
Returns By Period
In the year-to-date period, WDNA achieves a -13.52% return, which is significantly lower than XBI's 2.37% return.
WDNA
-13.52%
-3.72%
-8.38%
-13.63%
N/A
N/A
XBI
2.37%
-3.20%
-1.05%
4.32%
-1.28%
4.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
WDNA vs. XBI - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is higher than XBI's 0.35% expense ratio.
Risk-Adjusted Performance
WDNA vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
WDNA vs. XBI - Dividend Comparison
WDNA has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.14%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 0.00% | 0.80% | 0.37% | 0.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.14% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% | 0.17% |
Drawdowns
WDNA vs. XBI - Drawdown Comparison
The maximum WDNA drawdown since its inception was -51.90%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for WDNA and XBI. For additional features, visit the drawdowns tool.
Volatility
WDNA vs. XBI - Volatility Comparison
The current volatility for WisdomTree BioRevolution Fund (WDNA) is 7.42%, while SPDR S&P Biotech ETF (XBI) has a volatility of 7.92%. This indicates that WDNA experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.